An energy drink company just reported sentiment so flat that a consensus calling for nearly 18% revenue growth barely registered with anyone still watching.

Read on for that setup plus a chemicals CEO writing million-dollar personal checks and a software name where the AI story finally showed up in the numbers.

Auto Parts

Dauch Corporation (NYSE: DCH) trades near $6.78 after second-quarter adjusted free cash flow jumped to $148.4 million from $48.7 million a year earlier. Sales reached $2.96 billion, while adjusted EBITDA nearly doubled to $389.6 million as the acquired Dowlais operations reshaped the business.

Management raised the bottom of its 2026 adjusted EBITDA outlook to $1.36 billion, leaving the range at $1.36 billion to $1.425 billion. Adjusted free cash flow guidance also improved to $260 million to $325 million, while expected merger synergies moved higher.

With an enterprise value near $5.68 billion, Dauch sits around four times the midpoint of that EBITDA outlook. The stock has already jumped almost 20% today, but you still have a large valuation discount if the integration delivers what management expects.

The Merger Is Starting to Show Up in Cash

Dowlais turned Dauch into a much larger drivetrain supplier, but the market wanted proof that scale would translate into cash. Higher synergy expectations and the stronger quarter give your valuation case something tangible beyond promises made when the acquisition closed.

Debt Is Why 4x Does Not Mean Easy Money

Dauch carries about $5.34 billion of debt against $1.01 billion in cash. Actual second-quarter free cash flow was only $15.8 million before adjustments for restructuring, acquisition, and integration costs. You need those expenses to fade and debt to fall before the low EBITDA multiple deserves a major rerating.

Government Services

Maximus Inc. (NYSE: MMS) trades near $59.68 after cutting full-year adjusted EPS guidance to $7.90 to $8.20. The reset came after the Department of Veterans Affairs temporarily paused performance incentives on its Medical Disability Exam contract, reducing expected fiscal 2026 earnings by about $0.35 per share.

The underlying quarter held up better. Adjusted EPS reached $2.22, while adjusted EBITDA margin improved to 15.0% from 14.7% a year earlier. Revenue fell 5% to $1.28 billion, but Federal Services margins still expanded to 18.6%.

At the midpoint of reduced guidance, Maximus trades around 7.4 times adjusted earnings. If the VA disruption proves temporary, you still have a profitable government contractor priced for considerably more damage.

The Cash Flow Story Is Already Recovering

Full-year free cash flow guidance now stands at $425 million to $475 million, putting the midpoint near $450 million. July collections reached $245 million from the delayed federal customer, strengthening your case that the ugly $137 million quarterly cash outflow was largely a timing problem.

A $400 Million Buyback Meets a Contract Risk

Maximus still has its entire $400 million repurchase authorization available after already retiring about 14% of its starting fiscal 2025 share count. A prolonged VA contract reset can keep the single-digit multiple firmly in place, so the timing of that incentive restart matters if you are counting on a rerating.

Restaurants

The Wendy’s Company (NASDAQ: WEN) trades near $7.39 after withdrawing its 2026 outlook and cutting the annualized dividend from $0.56 to $0.28 per share. U.S. same-restaurant sales fell 7%, while adjusted EBITDA dropped 15.4% to $124.1 million as weaker traffic and higher costs pressured the business.

Cash generation held up better than the operating results. First-half free cash flow increased 9.9% to $120.3 million, while the stock now trades near 11 times trailing earnings and just 5.3 times trailing free cash flow.

Wendy’s market value has fallen to roughly $1.41 billion, and the share count is down almost 5% over the past year. Trian controls more than 24% of the stock, while management is targeting more than 300 weak restaurants for closure and rebuilding pricing, menu strategy, and franchise economics. That leaves your turnaround case with real upside if traffic finally stabilizes.

The Equity Looks Cheaper Than the Business

Wendy’s carries about $4.07 billion of debt against $341 million in cash, pushing enterprise value to $5.14 billion and EV/EBITDA near 8x. The headline 5x cash-flow multiple therefore makes the stock look cheaper than the full capital structure really is.

Debt Changes the Valuation Math

The dividend cut preserves more cash for a turnaround that still has plenty to prove. Falling traffic, weaker restaurant margins, and heavy leverage remain the obstacles, so if you want the rerating, the next evidence has to come from better store economics rather than another round of financial adjustments.

Baxter International (NYSE: BAX)

Baxter is the boring turnaround nobody wants to own, which is usually where the money is. Management raised revenue guidance in Q2, cost savings are landing on the income statement instead of living in a slide deck, and the medical products franchise is finally growing again after two years of dead money.

Your catalyst is not one event; it is a run of quarters where execution keeps clearing a lowered bar until the market updates its assumptions. This is a twelve-month re-rating, not a twelve-day one, so patience is part of the trade. The risk is hospital capital spending softening before the cost savings fully show up.

InterDigital (NASDAQ: IDCC)

InterDigital lifted its 2026 outlook, and the market barely blinked, which tells you how split the crowd is here. The analyst narrative points to real upside while a discounted cash flow read lands well below the current price, and that disagreement is precisely why the stock keeps getting written off as a one hit wonder.

What breaks the tie is the next round of licensing wins with Chinese handset makers, because those deals are lumpy but each one lifts the recurring earnings base permanently. The cash flow is real even when the models cannot agree what it is worth. The risk is negotiations dragging or a counterparty choosing litigation over a signature.

Nordson (NASDAQ: NDSN)

Nordson reports fiscal Q3 later this month, and be honest with yourself about what this is. It is a quality machinery leader trading at a full price, not a discount. The P/E sits above both the machinery group and the fair ratio, which caps how much multiple expansion is realistically on the table.

What you are paying for is a rebuilding backlog and the chance that orders finally inflect after a soft stretch. A beat-and-raise with real color on China demand normalization is what moves it. At this multiple, an in-line quarter is a disappointment.

That's our coverage for today; thanks for reading! Reply to this email with feedback or any stocks you want me to check out.

Best Regards,
—Noah Zelvis
Undervalued Edge